Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Permanently Discontinued

LIBTAYO

SANOFI-AVENTIS CANADA INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is LIBTAYO discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that LIBTAYO 250MG has been permanently discontinued (last updated December 9, 2023). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is LIBTAYO not available?

The reason the manufacturer reported: Business reasons.

Can I still get this?Possibly — same-ingredient product records found
StatusPermanently Discontinued
Same-ingredient products on file1 product
Affected strength250MG
Last updated2023-12-09

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

LIBTAYO

REGENERON CANADA COMPANY

350MG · DIN 02487144

Different strengthSame dosage formSame routeNo current shortage

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02487152

Strength

250MG

Dosage Form

SOLUTION

Route

INTRAVENOUS

Active Ingredient

CEMIPLIMAB

See all CEMIPLIMAB products →

Shortage History